Most recently, Rivus Pharmaceuticals raised $57.0M in its Later Stage VC (Jan 2025).
- ·Watch Rivus Pharmaceuticals: the Monday email on marks, rounds and moves
Rivus Pharmaceuticals round by round
4 roundsHow much has Rivus Pharmaceuticals raised?
Rivus Pharmaceuticals has raised $224 million across 4 recorded rounds since 2019. The largest was a $66 million later-stage round in Aug 2024; the most recent was a $57 million later-stage round in Jan 2025.
Rivus Pharmaceuticals has filed 4 Form Ds with the SEC since 2021, most recently in Jan 2025 ($57 million sold to 7 investors).
Rivus Pharmaceuticals investors
6 investors are on record for Rivus Pharmaceuticals, including RA Capital Management, Longitude Capital, Bain Capital Life Sciences and BB Biotech. The later-stage round in Jan 2025 drew 7 investors.
6 investors have backed Rivus Pharmaceuticals — start your target list with the firms already writing checks in drug discovery.
Frequently asked about Rivus Pharmaceuticals
- How much has Rivus Pharmaceuticals raised?
- Rivus Pharmaceuticals has raised $224.0M in total across 4 recorded funding rounds.
- When was Rivus Pharmaceuticals's last funding round?
- Rivus Pharmaceuticals's most recent recorded round was Later Stage VC in Jan 2025, raising $57.0M.